Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. (Q48589531)

13 February 2018

title

Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. (English)

1 reference

13 February 2018

0 references

M A Lovell

1

1 reference

13 February 2018

W D Ehmann

series ordinal

2

1 reference

13 February 2018

M P Mattson

series ordinal

3

1 reference

13 February 2018

W R Markesbery

series ordinal

4

1 reference

13 February 2018

publication date

1 September 1997

1 reference

13 February 2018

published in

Neurobiology of Aging

1 reference

13 February 2018

volume

18

1 reference

13 February 2018

issue

5

1 reference

13 February 2018

page(s)

457-461

1 reference

13 February 2018

Evidence of an oxidative challenge in the Alzheimer's brain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Effects of diffusible products of peroxidation of rat liver microsomal lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Are reactive oxygen species involved in Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

4-Hydroxynonenal, an aldehydic product of lipid peroxidation, impairs signal transduction associated with muscarinic acetylcholine and metabotropic glutamate receptors: possible action on G alpha(q/11).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Oxidative stress, glutamate, and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Oxidative stress hypothesis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Evidence for a membrane defect in Alzheimer disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

A radical hypothesis for neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Effect of 4-hydroxylalkenals on hepatic phosphatidylinositol-4,5-bisphosphate-phospholipase C.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Elemental imbalances in the olfactory pathway in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Oxidative damage in Alzheimer's.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Involvement of free radicals in dementia of the Alzheimer type: a hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

Fluorometric liquid chromatographic determination of aliphatic aldehydes arising from lipid peroxides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900108-5

7 January 2021

10.1016/S0197-4580(97)00108-5

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

9390770

1 reference

13 February 2018